Quick Answer
Treatment-resistant bipolar depression means depressive episodes haven't improved enough despite treatment. First, confirm the diagnosis, check that medication trials were adequate, and look for thyroid problems, substances or sleep disruption. Five atypical antipsychotics are FDA-approved for bipolar depression, and NIMH notes ECT can help severe cases.
Key Takeaways

- Five atypical antipsychotics, cariprazine, lumateperone, lurasidone, olanzapine-fluoxetine and quetiapine, are FDA-approved for bipolar depression, per a 2024 network meta-analysis.
- NIMH notes ECT is usually considered when other treatments haven't worked, or when rapid response is needed.
- NIMH notes TMS is a brain stimulation option that doesn't need anesthesia.
- STEP-BD research found adjunctive psychosocial treatment, not adjunctive antidepressants, improved outcomes over mood stabilizers alone.
When bipolar depression won't lift
Depressive episodes are often the hardest part of bipolar disorder: they tend to last longer than highs, and they can resist treatment. If you’ve tried several medications and still spend months in the lows, it’s easy to lose hope. There’s usually more to try, and sometimes the first step is looking again at what’s already been done. This guide is part of our South Carolina bipolar depression guide.
The checklist
- Is the diagnosis right, including bipolar I vs. II and any mixed features?
- Has each medication been tried at an adequate dose for long enough?
- Is an antidepressant being used alone, which NIMH advises against?
- Are thyroid problems, which NIMH notes can mimic bipolar symptoms, or lithium-related thyroid changes addressed?
- Are alcohol, cannabis or other substances involved?
- Is sleep regular, and are routines steady?
- Has psychotherapy been part of the plan?
A diagnosis review comes first: confirming bipolar I vs. II, mixed features and co-occurring conditions can change the whole plan. Next, list the FDA-approved options already tried and those that haven’t been. ECT for bipolar depression stays on the table for severe or dangerous episodes.
Why bipolar depression is so stubborn
Research summarized from the NIMH-funded STEP-BD program describes bipolar depression as the more pervasive pole of the illness, with a poorly responsive course despite combination strategies. That can feel discouraging, but it also means persistent lows are not a personal failure or a sign that you’re doing something wrong. It reflects the illness itself, and it’s why careful, step-by-step adjustment, therapy and attention to sleep and routine matter so much.
Persistence usually pays off.
A fresh look often helps.
Myths about hard-to-treat bipolar depression
Myth: If two medications failed, nothing will work.
There are five FDA-approved atypical antipsychotics for bipolar depression, plus mood stabilizers, combinations and brain stimulation.
Myth: Adding an antidepressant is the obvious next step.
The STEP-BD trial in the New England Journal of Medicine found adding a standard antidepressant to a mood stabilizer gave no extra benefit.
Myth: ECT is a last resort from the past.
NIMH describes ECT as a procedure that can relieve severe symptoms of bipolar disorder.
Myth: Therapy doesn't matter once medications are involved.
STEP-BD research found adjunctive psychosocial treatment improved outcomes over mood stabilizers alone.
Keeping hope realistic
Not every step works, but many people find a combination that lifts depression and keeps it away, sometimes after several tries. Setting practical goals, such as getting back to work, sleeping regular hours or reconnecting with family, helps you and your clinician see progress and decide what to adjust next.
Asking for a second opinion is reasonable and common in bipolar care.

Options to discuss
| Approach | Examples | Notes |
|---|---|---|
| An FDA-approved medication not yet tried | Cariprazine, lumateperone, lurasidone, olanzapine-fluoxetine, quetiapine | Choice depends on side effects and history |
| Combination | Lurasidone with lithium or valproate | Listed first-line in the 2018 CANMAT/ISBD guidelines, per a 2024 review |
| Mood stabilizer optimization | Lithium, lamotrigine, valproate | Levels and doses checked |
| Psychotherapy | Interpersonal and social rhythm therapy, family-focused therapy, CBT | Adds benefit alongside medication |
| Brain stimulation | ECT, TMS | ECT for severe cases or rapid response |
A 2024 network meta-analysis in European Psychiatry found all five FDA-approved atypical antipsychotics had higher response rates than placebo. Our guides on switching vs. augmenting and quetiapine vs. lurasidone cover specific decisions.
Getting a specialist review
Treatment-resistant bipolar care in South Carolina starts with a detailed review of every medication you’ve tried, with doses, durations and responses, plus labs, sleep, substance use and any past highs. First visits run 30 to 60 minutes by secure video anywhere in South Carolina or in person in Bluffton, and labs can be drawn locally. The practice is in-network with Aetna and Cigna, and self-pay fees are listed on the Good Faith Estimate page. Our second opinion consultations are designed for this kind of review.
What to bring to a review
- Every mood medication you’ve taken, with doses, how long and what happened
- Any antidepressant that seemed to trigger highs
- Recent labs, including thyroid and lithium or valproate levels
- A mood chart or notes on episodes
- Sleep patterns and substance use
- Therapy history
Bring a family member if that helps you remember details.

Where to go from here
- Right now, if you're not safe
- Call or text 988, or call 911.
- If you'd like an evaluation
- See how scheduling, labs and telehealth work on the new patient page.
- If you want to keep reading
- See switching vs. augmenting, or return to our guide to bipolar depression treatment in South Carolina. For more help preparing and finding care, see NIMH’s tips for talking with your health care provider and FindTreatment.gov.
The Bottom Line
When bipolar depression hasn't lifted, check the diagnosis, the adequacy of each trial and hidden contributors first. Several FDA-approved medications, combinations and ECT remain as options.
How We Reviewed This Page
Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.
What’s new: September 29, 2026. Page published.
References
- National Institute of Mental Health. Bipolar Disorder (NIH Publication No. 25-MH-8088, revised 2025). https://www.nimh.nih.gov/health/publications/bipolar-disorder
- Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis. European Psychiatry (2024). PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988162/
- Sachs GS et al. Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. New England Journal of Medicine (2007). https://www.nejm.org/doi/full/10.1056/NEJMoa064135
- Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC6493527/
- 988 Suicide & Crisis Lifeline. https://988lifeline.org
- Tips for talking with your health care provider. https://www.nimh.nih.gov/health/publications/tips-for-talking-with-your-health-care-provider
- FindTreatment.gov. https://findtreatment.gov/
Frequently Asked Questions
What counts as treatment-resistant bipolar depression?
There's no single definition, but it generally means depressive episodes haven't improved enough despite adequate trials of appropriate medications. A review often finds options that haven't been tried. A diagnosis review comes first: confirming bipolar I vs. II, mixed features and co-occurring conditions can change the whole plan. Next, list the FDA-approved options already tried and those that haven't been. ECT for bipolar depression stays on the table for severe or dangerous episodes.
Is ECT safe for bipolar depression?
NIMH describes ECT as able to relieve severe symptoms of bipolar disorder and notes it's usually considered when other treatments haven't worked or rapid response is needed. It's done under anesthesia in a hospital setting. Depressive episodes are often the hardest part of bipolar disorder: they tend to last longer than highs, and they can resist treatment. If you've tried several medications and still spend months in the lows, it's easy to lose hope. There's usually more to try, and sometimes the first step is looking again at what's already been done.
Why is bipolar depression so stubborn?
Research summarized from the NIMH-funded STEP-BD program describes bipolar depression as the more pervasive pole of the illness, with a poorly responsive course despite combination strategies. That can feel discouraging, but it also means persistent lows are not a personal failure or a sign that you're doing something wrong. It reflects the illness itself, and it's why careful, step-by-step adjustment, therapy and attention to sleep and routine matter so much. Persistence usually pays off. A fresh look often helps.
What should I know about keeping hope realistic?
Not every step works, but many people find a combination that lifts depression and keeps it away, sometimes after several tries. Setting practical goals, such as getting back to work, sleeping regular hours or reconnecting with family, helps you and your clinician see progress and decide what to adjust next. Asking for a second opinion is reasonable and common in bipolar care. A 2024 network meta-analysis in European Psychiatry found all five FDA-approved atypical antipsychotics had higher response rates than placebo. Our guides on switching vs. augmenting and quetiapine vs. lurasidone cover specific decisions.
How long should I try a bipolar depression medication before changing?
Many medications need several weeks at an adequate dose to judge whether they help. Changing too early can mean missing a medication that would have worked. Your prescriber will check doses and adherence before switching. Tracking symptoms helps show progress. Decisions are made together. Keeping notes on each trial helps avoid repeating medications that didn't work.
Can lithium help treatment-resistant bipolar depression?
Lithium can be helpful for bipolar depression and is often considered when other options haven't worked. It also has evidence for lowering suicide risk. Lithium requires regular blood level monitoring and kidney and thyroid checks. Your prescriber will explain whether it fits your situation. Our guides on lithium explain monitoring.

